View More Recent Stories
-
Krystal Biotech (KRYS) PT Raised to $221 at H.C. Wainwright
-
Stifel Reiterates Buy Rating on Krystal Biotech (KRYS)
-
Krystal Biotech's (KRYS) Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301
-
Krystal Biotech, Inc. (KRYS) Misses Q2 EPS by 25c Provides Outlook
